🇺🇸 FDA
Patent

US 9816075

Compounds with modifying activity enhanced under hypoxic conditions

granted A61KA61K31/435A61K49/0017

Quick answer

US patent 9816075 (Compounds with modifying activity enhanced under hypoxic conditions) held by The Board of Regents of the University of Texas System expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/435, A61K49/0017